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Diagnostic utility of patient history, clinical
examination and screening tool data to
identify neuropathic pain in low back
related leg pain: a systematic review and
narrative synthesis
Jai Mistry1,2, Nicola R. Heneghan2 , Tim Noblet1,2 , Deborah Falla2 and Alison Rushton2*
Abstract
Background: Low back-related leg pain (LBLP) is a challenge for healthcare providers to manage. Neuropathic pain
(NP) is highly prevalent in presentations of LBLP and an accurate diagnosis of NP in LBLP is essential to ensure
appropriate intervention. In the absence of a gold standard, the objective of this systematic review was to evaluate
the diagnostic utility of patient history, clinical examination and screening tool data for identifying NP in LBLP.
Methods: This systematic review is reported in line with PRISMA and followed a pre-defined and published protocol.
CINAHL, EMBASE, MEDLINE, Web of Science, Cochrane Library, AMED, Pedro and PubMed databases, key journals and
the grey literature were searched from inception to 31 July 2019. Eligible studies included any study design reporting
primary diagnostic data on the diagnostic utility of patient history, clinical examination or screening tool data to
identify NP in LBLP, in an adult population. Two independent reviewers searched information sources, assessed risk of
bias (QUADAS-2) and used GRADE to assess overall quality of evidence.
Results: From 762 studies, 11 studies were included. Nine studies out of the 11 were at risk of bias. Moderate level
evidence supports a cluster of eight signs (age, duration of disease, paroxysmal pain, pain worse in leg than back,
typical dermatomal distribution, worse on coughing/sneezing/straining, finger to floor distance and paresis) for
diagnosing lumbosacral nerve root compression, demonstrating moderate/high sensitivity (72%) and specificity (80%)
values. Moderate level evidence supports the use of the StEP tool for diagnosing lumbar radicular pain, demonstrating
high sensitivity (92%) and specificity (97%) values.
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Conclusions: Overall low-moderate level evidence supports the diagnostic utility of patient history, clinical
examination and screening tool data to identify NP in LBLP. The weak evidence base is largely due to methodological
flaws and indirectness regarding applicability of the included studies. The most promising diagnostic tools include a
cluster of 8 patient history/clinical examination signs and the StEP tool. Low risk of bias and high level of evidence
diagnostic utility studies are needed, in order for stronger recommendations to be made.
Keywords: Neuropathic pain, Low back related leg pain, Diagnosis, Systematic review
Background
One of the most prominent causes for worldwide dis-
ability is chronic pain, and up to a fifth of those with
chronic pain have neuropathic pain (NP) [1]. NP is de-
fined by the International Association for the Study of
Pain (IASP) as “pain arising from a disease or lesion of
the somatosensory nervous system” [2]. It has been esti-
mated that up to 1 in 10 people with chronic pain have
NP, this is according to point prevalence estimates ob-
tained from different time points between 2004 and
2012 [3]. NP is particularly common in those with low
back related leg pain (LBLP) [4], with point prevalence
estimates, taken between 2009 and 2012, and ranging
between 19 and 80% [5]. The annual direct medical costs
associated with NP in LBLP is estimated to be approxi-
mately £270 million in the UK alone [6], with the
current figure likely to be higher.
LBLP is considered primarily neuropathic in nature
when neural tissue in the low back is compromised (e.g.
nerve root, dorsal root ganglion), commonly referred to as
sciatic or lumbar radicular pain [5]. However, LBLP is not
always neuropathic in nature. LBLP can manifest as a re-
sult of the involvement of non-neural structures (e.g.
muscle, ligament, disc) in the lumbar spine (which simi-
larly can refer pain into the leg); termed as referred pain
and commonly associated with nociceptive pain [5]. How-
ever, it is well understood that pain does not simply
present dichotomously but as a complex interaction of nu-
merous pain mechanisms, as depicted in research
investigating the neurobiological basis of lumbar radiculo-
pathy, where NP, ischaemic and mechanical pain mecha-
nisms were found to coexist [7].
The importance of identifying the presence of NP in
LBLP is related to ensuring appropriate treatment interven-
tion. The National Institute for Health and Care Excellence
(NICE) guidelines for LBP with sciatica [8] recommend that
the pharmaceutical management of sciatica is to conform
with the NICE guidelines for NP [9]. Pain medication tar-
geted at treating the underlying pain mechanisms is advo-
cated as more effective than those that target a disease
entity [10].
There is no gold standard to diagnosing NP in LBLP,
furthermore there is no gold standard for diagnosing NP
[11]. Screening tools to identify NP in LBP have been
developed and validated, such as the Standardised Evalu-
ation of Pain questionnaire (StEP) [12], PainDetect [13]
and the Leeds Assessment of Neuropathic Symptoms and
Signs (LANSS) [14]. However, these tools are yet to be
validated in identifying NP in LBLP and, the literature re-
garding superiority of one over the other is varied and
conflicting [13, 15]. Similarly, research investigating the
use of patient history and clinical examination items to
diagnose NP in LBLP is lacking and inconclusive [16, 17].
Two separate studies have devised a list of clinical indica-
tors using patient history and clinical examination items
to identify peripheral NP in patients with or without leg
pain [18] and in lumbosacral nerve root compression [19].
The derived lists share one common item - pain distrib-
uted in a dermatomal pattern. However, these studies
must be observed with caution as items were considered
in a cluster and the phenomena of interest in both studies
are differently defined and thus difficult to compare dir-
ectly. To date there has been no systematic review investi-
gating the diagnostic utility of clinical indicators (patient
history, clinical examination and screening tools) to iden-
tify NP in LBLP.
Objective
To evaluate the diagnostic utility of patient history, clin-
ical examination and screening tool data in order to
identify NP in adults presenting with LBLP.
Methods
Design
A systematic review was completed in accordance with a
published study protocol [20]. The protocol was informed
by the The Cochrane Handbook for Diagnostic Test Accur-
acy studies and the Centre for Reviews and Dissemination
[21] and the Preferred Reporting Items for Systematic Re-
views and Meta-Analysis-Protocols (PRISMA-P) checklist
[22]. The systematic review is registered with PROSPERO
(CRD42019140861). No changes were made to the original
protocol [20].
Eligibility criteria
The Sample, Phenomenon of Interest, Design, Evalu-
ation, Research Type (SPIDER) guidelines were adopted
to format and structure the eligibility criteria [23].
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Inclusion criteria
(S) Sample: adult participants with LBLP.
(PI) Phenomenon of Interest: clinical indicators that
identify NP in LBLP.
(D) Design: non-experimental cross-sectional study de-
signs are the ideal design for investigating diagnostic ac-
curacy [24], and therefore optimal for this study.
However, other study designs were eligible for inclusion
if the study presented primary diagnostic accuracy data.
(E) Evaluation: studies investigating the validity of clin-
ical indicators to identify NP in LBLP.
These clinical indicators included:
– Patient History items (e.g. aggravating factors, pain
location, pain description)
– Clinical examination items (e.g. neurodynamic
testing, neurological examination, range of
movement)
– Screening tools (e.g. LANSS, StEP)
(R) Research type: quantitative or mixed methods (re-
quires relevant quantitative findings of results)
Exclusion criteria
– Not written in English
– Studies that did not compare an index test (patient
history and/or clinical examination and/or screening
tools) against a reference standard to identify NP in
LBLP [20]
Information sources
Two independent authors (JM, TN) independently
searched pre-identified electronic databases (searched
from inception to 31 July 2019), key journals and grey
literature.
Searches comprised of:
– Electronic databases: CINAHL, EMBASE,
MEDLINE, Web of Science, Cochrane Library,
AMED, Pedro and PubMed
– Key journals: Musculoskeletal Science and Practice,
PAIN, European Journal of Pain, The Journal of Pain
and The Clinical Journal of Pain
– Grey literature: British National bibliography,
OpenGrey and EThOS
Search strategy
The search was highly sensitive, devised in collaboration
with all authors and a specialist librarian [20]. The key
terms used for the search were: Diagnostic validity, Pa-
tient history, Clinical examination, Screening tool,
Neuropathic pain and LBLP.
For the above search terms a list of synonyms and
truncations were generated to maximise search
inclusion. Key terms were formatted as per the
requirements of each specific database in order to
retrieve the maximum number of relevant articles.




Endnote Version X8 (Clarivate Analytics) software
programme was used for data management [20]. Ab-
stracts and full texts were compiled and duplicates were
removed.
Box 1: Example of MEDLINE OvidSP search strategy
1948 – July 2019
1. exp. “Sensitivity and Specificity”/ or Diagnostic
accuracy.mp.
2. diagnostic utility.mp.
3. exp. “Reproducibility of Results”/ or exp. “Sensitivity and
Specificity”/ or diagnostic reliability.mp.











15. case ascertainment tool$.mp.
16. screening tool$.mp.
17. questionnaire$.mp. or exp. “Surveys and Questionnaires”/
18. 5 or 6,7,8,9,10,11,12,13,14,15,16,17
19. 4 and 18
20. neuropathic pain.mp. or exp. Neuralgia/
21. radicular.mp. or exp. Radiculopathy/ or exp. Intervertebral
Disc Displacement/ or exp. Spinal Nerve Roots/
22. exp. Sciatic Neuropathy/ or exp. Sciatic Nerve/ or sciatic$.mp.
23. 20 or 21 or 22
24. 19 and 23
25. low back pain.mp. or exp. Back Pain/ or exp. Low Back Pain/
26. low back related leg pain.mp. or exp. Sciatica/
27. 25 or 26
28. 24 and 27
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Selection process
Two reviewers (JM, TN) conducted a two staged selection
process, independently. Firstly, screening of titles and
abstracts was completed using the eligibility criteria.
Secondly, full texts of prospective studies were obtained
and then assessed for eligibility. Any disagreements
between reviewers throughout the selection process were
discussed and if a solution was not achieved then a third
reviewer was consulted (AR). Agreement throughout the
selection process between reviewers was measured using
the kappa statistic [25].
Data collection and data items
The data extraction document was piloted and
subsequently used without any modifications required,
independently, by the two reviewers (JM, TN). The third
reviewer (AR) was again used to settle any disagreements
as well as to ensure quality by independently reviewing
data extracted.
Extracted data items consisted of: title, author, publica-
tion date, study design, participant age, participant gender,
participant comorbidities, index test, comparator test,
reference standard, sensitivity, specificity, likelihood ratios
(LRs) and positive predictive values (PPVs).
Risk of bias
The Quality Assessment of Diagnostic Accuracy Studies
2 (QUADAS-2) tool was used as it is a recognised tool
for assessing risk of bias (RoB) in diagnostic accuracy
studies [26]. The four domains of the QUADAS-2 tool
(patient selection, index test, reference standard and flow
and timing) were independently assessed and judged by
each reviewer (JM, TN) as ‘high’, ‘low’ or ‘unclear risk’.
Reviewers then provided an overall verdict regarding
bias of the studies assessed, ‘at RoB’ or ‘low risk’, if a
study was judged as “high risk” or “unclear risk” in one
or more domains then an overall judgement of “at RoB”
was made [26]. The third reviewer (AR) was used to
settle disagreements if consensus was not achieved
between the two reviewers (JM, TN) on discussion.
Furthermore, agreement was assessed between the
reviewers (JM, TN) using Cohen’s k.
Summary measures
Summary measure tables were developed using the
primary diagnostic data (sensitivity, specificity, LRs and
PVs) retrieved from the included studies. Where data were
not available the lead author (JM) used the raw data to
calculate the missing results, using the formulae
recommended by Akobeng [27]. Sensitivity and specificity
cut of points were graded as low (≤50%), low/moderate
(51–64%), moderate (65–74%), moderate/high (75–84%)
and high (≥85%) as highlighted in the study protocol [20].
Data synthesis
Heterogeneity was explored in relation to study design,
population, comparable diagnostic data and reference
standard to dictate the possibility of doing a meta-analysis.
The data extraction form was used to compare study
design, population and reference standards between
studies and the summary measure tables were used to
explore comparable diagnostic data. As stated in the study
protocol [20], in the event that a meta-analysis was not
possible a narrative synthesis would be conducted [28].
Confidence in cumulative evidence
The Grading of Recommendations, Assessment, Develop-
ment and Evaluations (GRADE) was used to assess the
level of evidence; the GRADE method was adapted for
diagnostic accuracy research (Table 1) [29]. The reviewers
(JM, TN) assessed each included study according to five
downgrading factors (RoB, inconsistency of evidence,
indirectness of evidence, imprecision of results and publi-
cation bias) in order to assign GRADE ranking. The
GRADE ranking process started with assigning an initial
level of quality of evidence based on study design (cross
sectional and cohort design considered high quality, any
other design considered low quality) and then assessing
the study against the downgrading factors to assign a final
judgement on level of evidence [20]. Publication bias was
suspected in situations where evidence was derived from a
number of small studies.
Results
Study identification
Initial searches using electronic databases and additional
sources resulted in 762 studies being retrieved. Following
duplicate removal and title and abstract screening, 16
studies remained for full text review. On completion of
full text screening, 5 studies were excluded and a subse-
quent 11 studies were included for analysis (Fig. 1).
Study characteristics
Table 2 depicts the characteristics of the 11 included
studies.
Study design
All studies used cross sectional observational study
designs. One study was a pilot study with a cross sectional
observational design [32].
Participants
In total 3908 participants were investigated across the 11
included studies, with ages ranging 30–70 years. One
study did not report the age of participants [33]. The
phenomena of interest varied significantly between
studies; two studies investigated lumbosacral nerve root
compression [19, 34], one study investigated participants
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with upper/mid lumbar nerve root compression [32] and
another looked specifically at L5 lateral stenosis [17]. Two
studies investigated peripheral NP and chronic low back
pain respectively [18, 30] with and without leg pain,
whereas Capra et al. [16] investigated sciatica with or
without lumbar pain. Poiraudeau et al. [31] investigated
participants with sciatica associated with disc herniation
and Walsh et al. [35] studied those with LBLP. Finally,
Urban et al. [33] investigated participants with NP in the
lower limb and Scholz et al. [12] investigated participants
with radicular pain.
Index test
Two studies investigated the diagnostic validity of NP
screening tools (S-DN4, ID Pain, painDETECT question-
naire, S-LANSS and StEP tool) [12, 30]. One study
investigated the diagnostic accuracy of patient history
data [34], whilst two studies investigated both patient
history data and clinical examination data [18, 19].
Finally the remaining six studies investigated the use of
clinical examination tests; Straight leg raise (SLR) [16],
Slump test [33], slump knee bend [32], nerve palpation
[35], standardised qualitative sensory testing (SQST)
[17], and bell test/hyperextension test [31].
Reference standard
The most commonly used reference standard test was
magnetic resonance imaging (MRI); this was used in six
of the included studies [16, 17, 19, 31, 32, 34], one of
which used MRI and/or another imaging technique
(computed tomography & saccoradiculography) as a
reference standard [31]. Four studies used clinical
judgement as a reference standard through a clinical
examination [12, 18, 30, 33]. Clinical judgement was
defined in each of the four studies as; a single physician
examination [30], an experienced Rheumatologist,
Neurosurgeon and Physiotherapist examination [12], a
Consultant in pain medicine and expert Physiotherapist
examination [18] and two Orthopaedic manual thera-
pists examination [33]. Years of experience was not
specified in any of the four studies. Finally, one study
used clinical examination tests as a reference standard;
Walsh et al. [35] used the SLR and the slump test as a
reference standard.
Table 1 Modified GRADE for diagnostic accuracy studies
Factors that determine and can decrease the quality
of evidence
Explanations and how the factor may differ from the quality of evidence for other
interventions
Study design Cross-sectional or cohort studies in patients with diagnostic uncertainty and direct
comparison of test results with an appropriate reference standard (best possible alternative
test strategy) are considered high quality and can move to moderate, low or very low
depending on other factors.
Risk of bias (limitations in study design and
execution)
Representativeness of the population that was intended to be sampled.
Patient selection: consecutive or random sample of patients enrolled? Case-control design
avoided? Did the study avoid inappropriate exclusions?
Independent comparison with the reference standard.
All enrolled patients should receive the index test and the reference standard test.
Diagnostic uncertainty should be given.
Is the reference standard likely to correctly classify the target condition?
Flow and timing: was there an appropriate interval between index test(s) and reference
standard?
Indirectness
Patient population, diagnostic test, comparison test
and indirect comparisons of tests
The quality of evidence can be lowered if there are important differences between the
populations studied and those for whom the recommendation is intended (in prior testing,
the spectrum of disease or co-morbidity); if there are important differences in the tests stud-
ied and the diagnostic expertise of those applying them in the studies compared to the set-
tings for which the recommendations are intended; or if the tests being compared are each
compared to a reference (gold) standard in different studies and not directly compared in the
same studies.
Panels assessing diagnostic tests often face an absence of direct evidence about impact on
patient-important outcomes. They must make deductions from diagnostic test studies about
the balance between the presumed influences on patient-important outcomes of any differ-
ences in true and false positives and true and false negatives in relationship to test complica-
tions and costs. Therefore, accuracy studies typically provide low quality evidence for making
recommendations due to indirectness of the outcomes, similar to surrogate outcomes for
treatments.
Important Inconsistency in study results For accuracy studies unexplained inconsistency in sensitivity, specificity or likelihood ratios
(rather than relative risks or mean differences) can lower the quality of evidence.
Imprecise evidence For accuracy studies wide confidence intervals for estimates of test accuracy, or true and false
positive and negative rates can lower the quality of evidence.
High probability of Publication bias A high risk of publication bias (e.g., evidence only from small studies supporting a new test,
or asymmetry in a funnel plot) can lower the quality of evidence.
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Risk of bias
Complete agreement was achieved between the two
reviewers for assessment of RoB, and thus the third
reviewer was not required. Two studies were assessed as
low RoB [12, 19], the remaining nine studies were con-
sidered at RoB (Table 3, Fig. 2). The primary concerns
in relation to the at RoB studies were blinding of index
and reference tests/insufficient description of procedures
involved in index and reference test (six studies), flow
and timing between tests (four studies) and patient
selection (three studies). For all of the eleven included
studies the reference standard for RoB and applicability
was scored largely as unclear. This is because in the
absence of a gold standard or clear recommendations/
guidelines to diagnose NP in LBLP it is unclear whether
the reference standards used in the studies correctly
classify the target condition. Table 3 and Fig. 2 depict
RoB and applicability concerns for each of the 11
included studies.
Synthesis of results
A meta-analysis was not completed since there were
inconsistencies in the reference standard used between
studies. Even amongst the studies that used the same
reference standard, differences were highlighted in how
it was measured [16, 17]. Furthermore, the majority of
studies were considered at RoB making any further
statistical analysis equally at RoB. Finally, the number of
studies retrieved for screening tools (n = 2) and patient
history taking (n = 3) were limited and the studies
investigating a clinical examination test used a wide
variety of different tests resulting in insufficient data for
pooling. A narrative synthesis was therefore conducted.
Patient history data
One study, at RoB, investigated patient history data [34] in
relation to diagnosing nerve root compression or herniated
disc in patients with LBLP. This study investigated 20
separate patient history items (Table 4). Of the 20 items,
Fig. 1 Study selection flow diagram
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moderate/high and high sensitivity values in both herniated
disc and nerve compression groups were observed for
health-related absenteeism (81 and 80% respectively) and in
subjective sensory loss (89 and 90% respectively). Having
had pain in the same leg previously demonstrated the
highest specificity, in both herniated disc and nerve
compression groups (90 and 91% respectively). Indirectness
of evidence was highlighted as a highly selective population
of patients were recruited (Table 5). Using GRADE, there is
low quality of evidence to support the use of Verwoerd
et al’s [34] patient history indicators in diagnosing nerve
root compression or herniated discs (Table 5).
Table 3 QUADAS 2 RoB assessment findings
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Patient history data and clinical examination data
Two studies investigated both patient history taking and
clinical examination findings together [18, 19], in relation
to diagnosing peripheral NP in LBP with or without leg
pain [18] and in suspected lumbosacral nerve root
compression [19]. Smart et al. [18] identified a cluster of
three signs and symptoms (pain referred in dermatomal
or cutaneous distribution, history of nerve injury,
pathology or mechanical compromise, pain/symptom
provocation with mechanical/movement tests) which
demonstrated a high sensitivity (86.3%) and specificity
(96%) (Table 4). This study was considered at RoB as
clinicians were aware of the reference standard before
issuing the index test. Furthermore, indirectness of
evidence was highlighted due the use of clinical judgement
as a reference standard without specifying what criteria
were used to make this judgement. Using GRADE, there
is a low level of evidence to support Smart et al’s [18]
cluster of signs and symptoms in diagnosing peripheral
NP in LBP (Table 5).
Vroomen et al’s [19] study was deemed to be low RoB.
Vroomen et al. [19] identified 8 signs (including patient
history and clinical examination signs) which were
predictive of lumbosacral nerve root compression demon-
strating moderate sensitivity (72%) and moderate/high
specificity (80%) (Table 4). This study shared one
common item with Smart et al’s [18] cluster; pain referred
in a dermatomal distribution. In both instances this
indicator was used in association with other indicators,
raw data were not available to assess this indicator in
isolation. Vroomen et al. [19] used MRI as a reference
standard, which has been questioned for its diagnostic val-
idity [36], furthermore this study was investigating lumbo-
sacral nerve root compression which does not necessarily
infer NP. Using GRADE, there is a moderate level of
evidence to support Vroomen et al’s [19] eight signs in
diagnosing lumbosacral nerve root compression (Table 5).
Six studies investigated the use of clinical examination
tests in isolation. All six studies were considered at RoB
[14, 16, 17, 31–33]. Two studies investigated the diagnos-
tic accuracy of the SLR test for identifying sciatica. Capra
et al. [16] found a low sensitivity (36%) and moderate spe-
cificity (74%) whilst Poiraudeau et al. [31] found the op-
posite, moderate/high sensitivity (79%) and low specificity
(37%) (Table 4). Indirectness was highlighted in both stud-
ies partly due to the use of imaging as a reference standard
(Table 5). Using GRADE, there is low level evidence to
support the use of the SLR test in diagnosing sciatica.
Poiraudeau et al. [31] also investigated three other tests
(Bell’s test, HE test, Crossed lasegue test) all of which
demonstrated low or low/moderate sensitivity and specifi-
city values (Table 4), expect for moderate/high specificity
found for the crossed lasegue test (83%). Using GRADE,
there is low level evidence to support Bell’s test, HE test
and Crossed lasegue test in diagnosing sciatica (Table 5).
The slump knee bend [32] was found to have high and
moderate/high sensitivity and specificity values (100, 83%)
diagnosing upper/mid lumbar nerve root compression,
similarly the slump test [33] had high and moderate/high
sensitivity and specificity values (91, 78%) diagnosing NP
in LBLP (Table 4). Low sample sizes were characteristic of
both these studies, with one being a pilot study [32]. Using
GRADE, there is very low evidence to support the
diagnostic utility of the slump knee bend and slump test
in diagnosing upper/mid lumbar nerve root compression
and NP in LBLP respectively (Table 5).
Nerve palpation was found to have moderate/high sensi-
tivity (83%) and moderate specificity (73%) in identifying
LBLP [35], the SLR and slump tests were used as reference
standards which led to serious indirectness being
highlighted in this study. Low quality of evidence supports
the use of nerve palpation in diagnosing LBLP, following
the use of GRADE (Table 5). SQST was found to have low/
moderate sensitivity (62%) and high specificity (95%) when
Fig. 2 QUADAS 2 RoB assessment findings
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detecting lumbar lateral stenosis of the L5 nerve root [17]
(Table 4). However, indirectness of evidence was
highlighted as the participants recruited into this study
were all surgical patients and therefore not fully representa-
tive of the target population for this review. Using GRADE
low level of evidence supports the use of SQST in diagnos-
ing lumbar lateral stenosis of the L5 nerve root (Table 5).
Screening tool data
One study investigated four screening tools; S-DN4 (Self-
completed douleur neuropathique, ID Pain, PDQ (painDE-
TECT questionnaire) and S-LANSS (Self-completed Leeds
Assessment of Neuropathic symptoms and Signs) [30] to
identify NP in LBP. Three of the screening tools were iden-
tified as having a range of low/moderate to high sensitivity
and specificity values; 58.5% & 98% (S-DN4), 70.7% &
84.3% (ID Pain), 76.8% & 78.4% (PDQ) (Table 4). However,
the S-LANSS was identified as having a low specificity of
13% (Table 4). This study was deemed at RoB as patient ap-
plicability was compromised, this was partly due to the re-
cruitment of patients with LBP with or without leg pain
which is not consistent with the target population for this
review. Furthermore, the reference standard, clinical judge-
ment, was not adequately described and thus subject to
bias. Additionally, this study was completed in a different
language and cross-cultural validation cut of points used
are yet to be validated. Using GRADE, there is low level of
evidence to support the diagnostic utility of the S-DN4, ID
Pain, painDETECT and S-LANSS tools in diagnosing NP
in LBP (Table 5). The StEP tool [12] was found to have a
high sensitivity (92%) and specificity (97%) when diagnosing
lumbar radicular pain, this evidence was found to be of low
RoB. Using GRADE, there is moderate level of evidence to
support the diagnostic utility of the StEP tool in diagnosing
lumbar radicular pain (Table 5).
Discussion
This is the first systematic review to investigate the
diagnostic utility of patient history, clinical examination
and screening tool data to identify NP in LBLP. The results
of this review highlight low-moderate level evidence sup-
porting the diagnostic utility of patient history, clinical
examination and screening tool data to identify NP in
LBLP. The most promising diagnostic tools include a clus-
ter of 8 patient history/clinical examination signs and the
StEP tool where moderate level evidence was found follow-
ing the use of GRADE. However, the moderate level of evi-
dence supporting these two clinical indicators are reflective
of data from single studies and therefore must be observed
with caution. Eleven studies were included in this review
and only two were at low RoB, therefore the conclusions
that can be made from this systematic review are limited,
however the findings have led to important recommenda-
tions of further targeted research.
Table 4 Summary measures table of Patient History data,
clinical examination data and screening tool data
*SLR straight leg raise
Figures in blue were calculated by the reviewers of this paper, raw data was
used from the original studies
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Slump knee bend 16 1 Upper/mid Cross Serious Serious No serious Serious Undetected ⨁◯◯◯
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In order to effectively investigate the diagnostic utility
of clinical indicators to diagnosis NP in LBLP a common
reference standard is needed which is used uniformly
within the literature and in clinical practice. Secondly,
consensus regarding accurate and consistent use of
terminology when referring to NP in LBLP (e.g. sciatica,
lumbar radicular, LBLP) is needed so that literature can
be collated and compared without confusion. Finally,
studies investigating diagnostic utility must be at low
RoB and a high level of evidence must support the use
of the investigated clinical indicators in diagnosing NP
in LBLP for recommendations to made based on their
findings. To ensure future studies are at a low RoB it is
essential that appropriate blinding of both the reference
and index tests are carried out, patient population is
fully representative of the target population and flow
and timing between tests is described in detail and
justified.
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aDowngraded due to being at “high risk” of bias
b Downgraded due to indirectness observed in study due to highly selective population
c Downgraded due to indirectness observed in study as imaging/examination/opinion were used as reference standards all of which are not validated to identify
NP in LBLP
d Downgraded due to indirectness observed in study as population comprised of exclusively surgical patients and thus not representative of those
managed conservatively
e Downgraded due to indirectness observed in study as reference standards were poorly specified. The use of MRI, CT and saccoradiculography are described
without any description of how each will be assessed
f Downgraded to low quality due to study design. This study was a pilot study
g Downgraded due to indirectness observed in study as small population size was not representative of target population
h Downgraded due to imprecision observed in study as wide confidence intervals noted for all measures of diagnostic accuracy. In particular positive predictive
value (22–96%)
i Downgraded due to indirectness observed in study as SLR and Slump test were used as a reference standard which are not validated tests to identify NP in LBLP
j Downgraded due to indirectness observed in study as population included those with LBP with or without leg pain which is not consistent with the target
population for this review. Also, the questionnaires used in this study were translated into Hindi and yet to be validated. Furthermore, the description of reference
standard, physician opinion, was inadequately described and thus indirect
k Downgraded due to indirectness observed in study as equipment needed for the StEP tool are not readily available in clinical practise
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Patient history and clinical examination
Patient history indicators to diagnose lumbosacral nerve
root compression have been investigated by Verwoerd
et al. [34] (low level of evidence), this study found moder-
ate/high sensitivity in; “health-related absenteeism”, high
sensitivity in “subjective sensory loss” and high specificity
in “having had pain in the same leg previously.” However,
there is no further evidence to support these patient
history indicators in diagnosing NP in LBLP. Clusters of
patient history and clinical examination indicators have
been highlighted by two studies in this review demonstrat-
ing high sensitivity and specificity in one study [18] and
moderate sensitivity and moderate/high specificity in the
other [19]. Low quality evidence supports a cluster of
three signs and symptoms in diagnosing peripheral NP
(pain referred in dermatomal or cutaneous distribution,
history of nerve injury, pathology or mechanical com-
promise and pain/symptom provocation with mechanical/
movement tests) [18]. Moderate level of evidence supports
the diagnostic utility of a cluster of eight signs in diagnos-
ing lumbosacral nerve root compression (two patient
characteristics - age and duration of disease, four symp-
toms from the history - paroxysmal pain, pain worse in
leg than back, typical dermatomal distribution, worse on
coughing/sneezing/straining and two signs from the phys-
ical examination - finger to floor distance and Paresis)
[19]. These two studies share only one common indicator;
pain referred in a dermatomal distribution. However, this
indicator was included as part of a cluster of signs/symp-
toms in both studies and therefore the diagnostic validity
of this indicator alone is unclear. The 2016 Neuropathic
Pain Special Interest Group (NeuPSIG) grading system
highlights that in order for NP to be probable or definite
pain/sensory signs must follow a neuroanatomically plaus-
ible distribution [37], which would encompass a dermato-
mal pattern, supporting the use of this clinical indicator.
Conversely, research investigating entrapment neuropa-
thies has demonstrated an extraterritorial spread of symp-
toms following mild sciatic nerve compression [38],
disputing the use of this indicator. Due to the lack of clar-
ity of the performance of this indicator in isolation and
the uncertainty in the literature, the diagnostic utility of
this patient history indicator remains unclear.
The SLR was found to have moderate/high sensitivity
and low specificity when diagnosing sciatica [31], however
on the contrary Capra et al. [16] found the opposite in
their study investigating sciatica (low sensitivity and mod-
erate specificity). Overall low level of evidence supports
the use of the SLR in diagnosing sciatica. The slump knee
bend [32] and slump test [33] were found to have high
sensitivity and moderate/high specificity in diagnosing
upper/mid lumbar nerve root compression and peripheral
NP in the lower limb respectively. Very low level of
evidence associated with both these tests were largely due
to the small sample sizes used in each study. Evidence to
support the use of neurodynamic testing to identify NP in
LBLP is conflicting with an increasing body of evidence
highlighting the low diagnostic validity of these tests [38].
SQST [17] demonstrated low/moderate sensitivity and
high specificity when diagnosing lumbar lateral stenosis
involving the L5 nerve root in a study at RoB. The popula-
tion of patients used were all surgical and therefore not
fully representative of the target population for this review,
thus the applicability of these findings is poor. There is
evidence to support the use of quantitative sensory testing
(QST) in diagnosing small fibre nerve degeneration in
entrapment neuropathies [39]. However, SQST differs to
QST as it describes tests which are inexpensive and
accessible within a clinical setting (e.g. coin for testing
temperature). Evidence to support SQST to detect small
fibre nerve degeneration is limited [40] and yet to be in-
vestigated in participants with LBLP. The sensory profiles
of those with NP in LBLP is not known and therefore sup-
port for SQST in identifying NP in LBLP is inconclusive.
Screening tools
A range of low/moderate to high sensitivity and specificity
values were found for S-DN4, ID Pain and PDQ in a study
investigating CLBP with or without leg pain [30]. This
study was found to be at RoB and indirectness was ob-
served due to inconsistencies in cross cultural validation.
Scholz et al. [12] found high sensitivity and specificity in
their study investigating the use of the StEP tool in identi-
fying lumbar radicular pain, this study was at low RoB.
Moderate level of evidence supports the diagnostic utility
of the StEP tool in diagnosing lumbar radicular pain.
However clinical judgement was used as a reference
standard which was not adequately described, furthermore
clinical judgement is not a validated means to identify NP
in LBLP. There is no further research to support the use
of the StEP tool in identifying NP in LBLP, further
research is needed to support its use.
Collective synthesis of patient history data, clinical
examination data and screening tool data
Collective synthesis of patient history data, clinical exam-
ination data and screening tool data
Primary diagnostic data reported in these studies support
the use of certain subjective history items, clinical examin-
ation items and screening tools, however due to the overall
RoB assessment and low level of evidence supporting the
use of clinical indicators these results must be observed
with caution. Only two studies were reported as low RoB
and demonstrated moderate level of evidence supporting
the diagnostic utility of a cluster of eight patient history/
clinical examination signs and the StEP tool in diagnosing
lumbosacral nerve root compression and lumbar radicular
pain respectively. However, due to the indirectness of these
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Table 6 Reasons for each risk of bias item
Capra et al., 2011 [16] Risk of bias
Flow and timing (high risk): high risk due to the time intervals between the reference standard, index
test and any other treatment administered was not stated in the study.
Applicability concerns
Reference standard (Unclear): unclear as there is no clear gold standard for diagnosing NP in LBLP
Gudala et al., 2017 [30] Risk of bias
Index test (Unclear): it was not stated if the index test was administered without prior knowledge of
reference standard results. Furthermore, the use of Physicians assessment as a gold standard was not
supported with any pre-defined threshold.
Reference standard (Unclear): it was not stated in the study whether the reference standard was
administered without prior knowledge of the index test results.
Applicability concerns
Reference standard (Unclear): unclear as there is no clear gold standard for diagnosing NP in LBLP
Lin et al., 2017 [17] Applicability concerns
Patient selection (high risk): The patient population selected for this study were exclusively surgical
patients and therefore not entirely consistent with the target population for this review.
Reference standard (Unclear): unclear as there is no clear gold standard for diagnosing NP in LBLP
Poiraudeau et al., 2001 [31] Risk of bias
Reference standard (high risk): examiner 1 of 3 was involved with initial patient clerking/examination
which may have influenced interpretation of reference standard results.
Flow and timing (high risk): All tests were done on the same day however the time intervals between
tests were not specified.
Applicability concerns
Reference standard (Unclear): unclear as there is no clear gold standard for diagnosing NP in LBLP
Scholz et al., 2009 [12] Applicability concerns
Reference standard (Unclear): unclear as there is no clear gold standard for diagnosing NP in LBLP
Smart et al., 2012 [18] Risk of bias
Index test (high risk): index test was conducted with knowledge of the results of the reference standard.
Applicability concerns
Reference standard (Unclear): unclear as there is no clear gold standard for diagnosing NP in LBLP
Trainor et al., 2011 [32] Risk of bias
Patient selection (high risk): convenience sampling was used to recruit patients.
Flow and timing (high risk): ‘small’ intervals were taken between each examiner conducting the index
test (slump knee bend test), which have influenced test result.
Applicability concerns
Patient selection: due to small sample size in this study the applicability to the wider target population
is poor.
Reference standard (Unclear): unclear as there is no clear gold standard for diagnosing NP in LBLP
Urban et al., 2015 [33] Risk of bias
Patient selection (high risk): convenience sampling was used to recruit patients.
Flow and timing (high risk): the index test was completed immediately after the clinical examination
(reference standard) which may have influenced the results of the index test.
Applicability concerns
Patient selection: due to small sample size in this study the applicability to the wider target population
is poor.
Reference standard (Unclear): unclear as there is no clear gold standard for diagnosing NP in LBLP
Verwoerd et al., 2014 [34] Risk of bias
Patient selection (Unclear): unclear how the patient population was recruited.
Index test (Unclear): It was not specified if the index test was completed without knowledge of the
reference standard results.
Applicability concerns
Patient selection (high risk): the patient population consisted of those with “severe sciatica” and
therefore not representative of those with mild and moderate symptoms.
Reference standard (Unclear): unclear as there is no clear gold standard for diagnosing NP in LBLP
Vroomen et al., 2002 [19] Applicability concerns
Reference standard (Unclear): unclear as there is no clear gold standard for diagnosing NP in LBLP
Walsh et al., 2009 [14] Risk of bias
Reference standard (high risk): The reference standard was a neurodynamic test which has been
found to have low diagnostic validity.
Flow and timing (high risk): the SLR and slump test were performed immediately after the nerve
palpation which may have affected the test findings.
Applicability concerns
Reference standard (Unclear): unclear as there is no clear gold standard for diagnosing NP in LBLP
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studies in relation to the central question of this review the
diagnostic utility of these indicators in regards to identifying
NP in LBLP remains unclear.
Indirectness highlighted in all of the included studies is
largely related to the phenomena of interest being investi-
gated and its consistency with the focus of this review in
identifying NP in LBLP. Included studies investigated the
diagnostic utility of clinical indicators in relation to identify-
ing; lumbosacral nerve root compression, L5 lateral sten-
osis, sciatica, LBLP and chronic LBP, all of which may
imply NP in LBLP but not explicitly. Without appropriately
defining in the study that NP in LBLP will be investigated,
the above-mentioned titles remain ambiguous. Further-
more, in studies where the phenomena of interest are
termed as such that imaging is needed to confirm them,
e.g. lateral stenosis, it could be questioned whether this an
appropriate approach to identify NP. It is well established
that structural abnormalities found on imaging are not al-
ways directly correlated with symptom presentation [36]. In
cases where sciatica is the phenomena of interest, without
specifying the interest of investigating the presence of NP
within this presentation, sciatica could also encompass
cases where NP is not present, as highlighted by Mahn
et al., [41]. This is also the case for studies that investigate
LBLP, as a manifestation of LBLP may be pain induced by
activation of the nervi nevorum (connective tissue sheaths
of the peripheral nerve) which result in increased mechano-
sensitivity which is deemed largely nociceptive in nature
and can occur without NP [39]. Furthermore, pain into the
leg originating from the back may also be as a result of
non-nervous tissue in the lumbar spine being implicated
(such as muscle, ligament, disc) which can follow a somatic
referred pattern into the leg [5].
As a result of the indirectness highlighted regarding
applicability concerns as well as the highly heterogenous
data, the studies have been largely assessed individually
and the limited synthesis made between studies have
been suggested with caution. Due to the general low
level of evidence, high RoB and indirectness of evidence
we believe that further research is needed to address the
title of this review.
Strengths and limitations
A strength of this systematic review is it adhered to a
pre-defined protocol which enabled robust identification
and synthesis of the available evidence. Through the
analysis that was carried out, recommendations for fu-
ture research have been made. In the absence of a gold
standard to diagnosis NP in LBLP there is no standar-
dised commonly used reference standard in its place,
this is a key limitation to this review. Therefore, the use
of imaging, clinical opinion and clinical tests used within
the included studies are questioned as it is unclear which
reference standard is superior. This in turn results in the
interpretation of the primary diagnostic accuracy data
generated from these studies being contentious, as the ref-
erence standard is subject to debate. Another limitation to
this study was that, due to the highly heterogeneous data
obtained from the included studies, a meta-analysis was
not possible. Furthermore, due to the general low level of
evidence supporting the investigated clinical indicators
and high RoB owing to a range of reasons (Table 6), the
conclusions made from this systematic review are limited.
Finally, the moderate level of evidence supporting the two
clinical indicators (a cluster of eight patient history/clinical
examination signs and the StEP tool) must be observed
with caution. The evidence used to support this level of
evidence is assessed from individual studies and therefore
despite being deemed ‘moderate level of evidence’ (follow-
ing the use of GRADE) the generalisability to a wider
population is poor.
Conclusion
Low-moderate level evidence supports the diagnostic util-
ity of patient history, clinical examination and screening
tool data to identify NP in LBLP. Issues relating to the
quality of evidence are largely due to methodological flaws
and issues regarding applicability of the included studies.
The most promising diagnostic tools highlighted in this
review include a cluster of eight patient history/clinical
examination signs and the StEP tool.
Recommendations for low RoB and high level of evi-
dence diagnostic utility studies have been made. Further-
more, a need for consistency in the use of terminology
relating to NP in LBLP and a common reference stand-
ard to identify NP in LBLP is needed in order for stron-
ger recommendations to be made.
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